Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPRING: DE-109 Extension in Uveitis
NCT02251938Phase 3Completed
- Sponsor
- Santen Pharmaceutical
- Start
- Sep 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of sirolimus in non-infectious posterior uveitis (NIPU), sponsored by Santen Pharmaceutical. Started Sep 2014; status: completed.
02
Drugs
sirolimus
03
Conditions
non-infectious posterior uveitis (NIPU)
Beyond the preview
Go deeper on NCT02251938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02251938.